Annual D&A
$67.00 K
+$9000.00+15.52%
December 31, 2023
Summary
- As of February 8, 2025, CMMB annual depreciation & amortization is $67.00 thousand, with the most recent change of +$9000.00 (+15.52%) on December 31, 2023.
- During the last 3 years, CMMB annual D&A has risen by +$43.00 thousand (+179.17%).
- CMMB annual D&A is now at all-time high.
Performance
CMMB Depreciation And Amortization Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Related metrics
Quarterly D&A
N/A
September 1, 2024
Summary
- CMMB quarterly depreciation & amortization is not available.
Performance
CMMB Quarterly D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Related metrics
TTM D&A
N/A
September 1, 2024
Summary
- CMMB TTM depreciation & amortization is not available.
Performance
CMMB TTM D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Related metrics
CMMB Depreciation And Amortization Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +15.5% | - | - |
| 3 y3 years | +179.2% | - | - |
| 5 y5 years | +179.2% | - | - |
CMMB Depreciation And Amortization Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +97.1% | ||||
| 5 y | 5-year | at high | +179.2% | ||||
| alltime | all time | at high | +179.2% |
Chemomab Therapeutics Depreciation And Amortization History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2023 | $67.00 K(+15.5%) | - | - |
| Jun 2023 | - | $16.00 K(0.0%) | $63.00 K(+3.3%) |
| Mar 2023 | - | $16.00 K(+14.3%) | $61.00 K(+5.2%) |
| Dec 2022 | $58.00 K(+70.6%) | $14.00 K(-17.6%) | $58.00 K(+5.5%) |
| Sep 2022 | - | $17.00 K(+21.4%) | $55.00 K(+17.0%) |
| Jun 2022 | - | $14.00 K(+7.7%) | $47.00 K(+17.5%) |
| Mar 2022 | - | $13.00 K(+18.2%) | $40.00 K(+17.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2021 | $34.00 K(+41.7%) | $11.00 K(+22.2%) | $34.00 K(+17.2%) |
| Sep 2021 | - | $9000.00(+28.6%) | $29.00 K(+3.6%) |
| Jun 2021 | - | $7000.00(0.0%) | $28.00 K(+7.7%) |
| Mar 2021 | - | $7000.00(+16.7%) | $26.00 K(+8.3%) |
| Dec 2020 | $24.00 K | $6000.00(-25.0%) | $24.00 K(+33.3%) |
| Sep 2020 | - | $8000.00(+60.0%) | $18.00 K(+80.0%) |
| Jun 2020 | - | $5000.00(0.0%) | $10.00 K(+100.0%) |
| Mar 2020 | - | $5000.00 | $5000.00 |
FAQ
- What is Chemomab Therapeutics annual depreciation & amortization?
- What is the all time high annual D&A for Chemomab Therapeutics?
- What is Chemomab Therapeutics annual D&A year-on-year change?
- What is the all time high quarterly D&A for Chemomab Therapeutics?
- What is the all time high TTM D&A for Chemomab Therapeutics?
What is Chemomab Therapeutics annual depreciation & amortization?
The current annual D&A of CMMB is $67.00 K
What is the all time high annual D&A for Chemomab Therapeutics?
Chemomab Therapeutics all-time high annual depreciation & amortization is $67.00 K
What is Chemomab Therapeutics annual D&A year-on-year change?
Over the past year, CMMB annual depreciation & amortization has changed by +$9000.00 (+15.52%)
What is the all time high quarterly D&A for Chemomab Therapeutics?
Chemomab Therapeutics all-time high quarterly depreciation & amortization is $17.00 K
What is the all time high TTM D&A for Chemomab Therapeutics?
Chemomab Therapeutics all-time high TTM depreciation & amortization is $63.00 K